Editorial: Science and Democracy
By San Francisco Chronicle,
San Francisco Chronicle
| 11. 13. 2005
NOW THAT California taxpayers know that the $3 billion ($6 billion with debt service) that they voted in 2004 to spend on stem-cell research may possibly be an outright grant of money for research rather than an investment, does it make a difference?
Does it matter that Robert Klein, the author and chief promoter of Proposition 71, knew while he was promising the voters a return on their investment that the state might be forbidden to collect royalties from the biomedical research it invests in because of an arcane federal tax law?
What was voters' intent in approving a plan to invest in a promising but financially risky new technology that may someday cure disease and save lives? Were they counting on a financial return, a new industry or promises of cures? And did they assume that they would be affordable to the majority of Californians?
It's important to know the answers to these, and other questions, before the California Institute of Regenerative Medicine, the agency created by the 2004 stem-cell initiative, begins awarding grants of taxpayer funds. Why? Because...
Related Articles
By Smriti Mallapaty, Nature | 09.11.2024
Under his microscope, Jun Wu could see several tiny spheres, each less than 1 millimetre wide. They looked just like human embryos: a dark cluster of cells surrounded by a cavity, and then another ring of cells.
But Wu, a...
By Antonio Regalado, MIT Technology Review | 08.22.2024
In 2016, I attended a large meeting of journalists in Washington, DC. The keynote speaker was Jennifer Doudna, who just a few years before had co-invented CRISPR, a revolutionary method of changing genes that was sweeping across biology labs because...
By Priyanka Runwal, Chemical and Engineering News | 08.05.2024
Saritee Sanodiya, 26, has spent countless days wondering if she’ll ever live a “normal” life. Growing up, Sanodiya often missed school, frequenting the hospital for sudden, life-threatening drops in her hemoglobin levels and excruciating pain in her joints. High fever...
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...